These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2504753)

  • 1. The integrity of generic drugs.
    Fisher DW
    Hosp Pract (Off Ed); 1989 Sep; 24(9):9. PubMed ID: 2504753
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic vs. brand name drugs--defining and enforcing standards.
    Lasagna LC
    Internist; 1979 May; 20(4):11, 13. PubMed ID: 10316827
    [No Abstract]   [Full Text] [Related]  

  • 3. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic bioequivalence: a scientific consensus needed.
    Am Fam Physician; 1987 Feb; 35(2):91, 95. PubMed ID: 3812175
    [No Abstract]   [Full Text] [Related]  

  • 5. Multinational medicines--ensuring drug quality in an era of global manufacturing.
    Okie S
    N Engl J Med; 2009 Aug; 361(8):737-40. PubMed ID: 19692686
    [No Abstract]   [Full Text] [Related]  

  • 6. How good are our drugs?
    Miller LC
    Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276
    [No Abstract]   [Full Text] [Related]  

  • 7. Benefits and liabilities of generic prescribing.
    Lee AM
    W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384
    [No Abstract]   [Full Text] [Related]  

  • 8. Determining drug equality.
    Hecht A
    FDA Consum; 1975 Nov; 9(9):18-20. PubMed ID: 10316633
    [No Abstract]   [Full Text] [Related]  

  • 9. Striving for standards in bioequivalence assessment: a review.
    Schulz HU; Steinijans VW
    Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):293-8. PubMed ID: 1743802
    [No Abstract]   [Full Text] [Related]  

  • 10. New York State and drug lists: a history of confusion.
    Stetler CJ
    Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687
    [No Abstract]   [Full Text] [Related]  

  • 11. Generic drugs: why all the fuss ... again?
    Williams RL
    Am Pharm; 1986 Sep; NS26(9):21-2, 47. PubMed ID: 3776832
    [No Abstract]   [Full Text] [Related]  

  • 12. Some thoughts on the generic equivalency debate.
    Berry FB
    Med Times; 1971 Sep; 99(9):199-201. PubMed ID: 5170858
    [No Abstract]   [Full Text] [Related]  

  • 13. Major events during the generic drug investigations.
    Am Pharm; 1990 Jul; NS30(7):38-9. PubMed ID: 2363392
    [No Abstract]   [Full Text] [Related]  

  • 14. Who really assures prescription drug quality?
    J Indiana State Med Assoc; 1979 Mar; 72(3):164. PubMed ID: 422862
    [No Abstract]   [Full Text] [Related]  

  • 15. Generic drugs. Save money--but is there a cost?
    Roberts SS
    Diabetes Forecast; 2002 Nov; 55(11):51-3. PubMed ID: 14768605
    [No Abstract]   [Full Text] [Related]  

  • 16. Lawsuits anticipated on generic biologicals front.
    Fox JL
    Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
    [No Abstract]   [Full Text] [Related]  

  • 17. Generic equivalency: does it exist?
    Payne RJ
    Med Ann Dist Columbia; 1969 Sep; 38(9):490-2. PubMed ID: 5259629
    [No Abstract]   [Full Text] [Related]  

  • 18. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic drug substitution revisited.
    Strom BL
    N Engl J Med; 1987 Jun; 316(23):1456-62. PubMed ID: 3553952
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of generic ophthalmic drugs.
    Novack GD
    Ocul Surf; 2013 Jan; 11(1):54-6. PubMed ID: 23321360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.